Company / Revenue per Share
Avidity Biosciences, Inc. Revenue per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.14
FY2025
5-year range
$0.10 / $0.23
FY2021-FY2025
Trend
+39.5%
vs FY2024
Sector context
#130 of 154
Health Care
What the data says
Avidity Biosciences, Inc.'s revenue per share of $0.14 is lower than 84% of companies in the Health Care sector (FY2025). Revenue per Share returned to growth in FY2025 after 5 years of decline, reaching $0.14.
Based on SEC 10-K filings.
0.14 in FY2025 with a 5-year CAGR of -15.3%.
Improved from $0.13 to $0.14 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -8.3%
- 5-Year CAGR
- -15.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 154This company $0.14 Sector average $15.09
▼
-99.1% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 39.5% year-over-year.
- Ranks #130 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2019.
- Lowest revenue per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.14 | +39.5% |
| FY2024 | $0.10 | -25.4% |
| FY2023 | $0.13 | -26.0% |
| FY2022 | $0.18 | -21.4% |
| FY2021 | $0.23 | -28.1% |
| FY2020 | $0.31 | -63.3% |
| FY2019 | $0.85 | +458.6% |
| FY2018 | $0.15 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026